ONE VCU: RESPONSIBLE TOGETHER - RETURN TO CAMPUS UPDATES AND RESOURCES Read more »
The visit with scientists, doctors and community leaders focused on community collaboration efforts aimed at health disparities and cutting-edge cancer research.
Read more »
What is it like to go to a health system every day to train as a future surgeon? Ashley Matthew, a first-year urology intern, explains.
The company is seeking emergency use authorization from the FDA. Its single-shot vaccine has huge implications for rural areas, according to a VCU infectious diseases expert.
With some VCU students already trained and others lined up for training, volunteers are ready to address the need for more COVID-19 vaccinators and take on roles that will serve them in their careers.
"We are working with state and local health departments to offer our patients the opportunity to receive the COVID-19 vaccine as quickly and safely as possible."
VCU Massey Cancer Center scientists shared their advances in the fight against cancer and their knowledge about how health disparities intersect with pancreatic, cervical and other cancers.
This afternoon, the First Lady of the United States, Jill Biden, Ed.D., will visit the VCU Massey Cancer Center and meet with researchers and community partners.
The decision is based on several factors, VCU President Michael Rao said, including an examination of COVID-19 positivity rates and a review of isolation space on campus.
Seniors and health care workers say safety — for them and members of their community — is the top reason they are getting the COVID-19 vaccine.
When it comes to talking about Black history and medical care, Davis, VCU Health director of diversity, equity and inclusion, has one major piece of advice: “Educate. Educate. Educate."
A study by a VCU School of Social Work professor digs for answers — and identifies several possible contributing factors.
View more »
Have a news tip or need help with a health-related story? Contact University Public Affairs at (804) 828-1231 or vcunews@vcu.edu.
Millions have received COVID-19 vaccines in the United States, but the information can be confusing. Johnson & Johnson is seeking emergency use authorization for its vaccine from the Food and Drug Administration. If approved, it would be the third available in the United States, joining vaccines from Moderna and Pfizer. VCU News spoke with Michael Stevens, M.D., associate chair of the Division of Infectious Diseases at the School of Medicine, about the differences between the vaccines.